Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$73,920
+$27,229 QoQ
Shares Held
264
+50.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#845
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $25,003,469 across 20 Diagnostics & Research names. LH ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,610 | $12,338,469 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,231 | $4,859,567 | |
| 3 | DHR |
Danaher Corp /De/
|
11,797 | $2,247,092 | |
| 4 | ILMN |
Illumina, Inc.
|
11,514 | $2,024,506 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
546 | $697,520 | |
| 6 | A |
Agilent Technologies, Inc.
|
4,187 | $556,159 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
2,084 | $472,630 | |
| 8 | RVTY |
Revvity, Inc.
|
3,686 | $410,104 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,920 | 264 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $46,691 | 175 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $34,119 | 136 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $35,021 | 122 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $21,525 | 82 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2 | 10 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $11,466 | 50 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2 | 8 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2 | 8 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||